Recent News

Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it

Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it

A team led by UNC Lineberger's Gianpietro Dotti, MD, has engineered immune cells to hunt glioblastoma, the most lethal primary brain tumor. They presented their findings in Science Translational Medicine.

Researchers identify molecular target for brain cancer, develop immunotherapy approach to attack it - Read More…

Mayer advising NCI on cancer survivorship issues and research

Mayer advising NCI on cancer survivorship issues and research

UNC Lineberger's Deborah K. Mayer, PhD, RN, AOCN, FAAN, will continue to work at UNC-Chapel Hill while providing counsel to the National Cancer Institute’s Division of Cancer Control and Population Sciences on issues related to cancer survivorship.

Mayer advising NCI on cancer survivorship issues and research - Read More…

Sellers named 2018 Health Care Hero

Sellers named 2018 Health Care Hero

Triangle Business Journal recognizes Jean Sellers, RN, MSN, for her work to improve access to high quality cancer care in North Carolina.

Sellers named 2018 Health Care Hero - Read More…

Phase I clinical trial shows some promise for investigational drug for melanoma

Phase I clinical trial shows some promise for investigational drug for melanoma

Three of 15 patients with BRAF-mutant melanoma had partial responses to an investigational compound in an early-stage study led by UNC Lineberger's Stergios Moschos, MD.

Phase I clinical trial shows some promise for investigational drug for melanoma - Read More…